Precision Isotopes for Global Health.
IsoMed Solutions utilizes proprietary Low-Enriched Uranium (LEU) technology to produce high-purity medical isotopes, ensuring a stable, domestic supply for diagnostic imaging and life-saving treatments.
99.9%
Purity Standard
12,000+
Patients Weekly
24/7
Global Logistics
Zero
Carbon Emission Goal
Our Technology
Redefining Enrichment for Medicine.
The world faces a critical shortage of Molybdenum-99 and other therapeutic isotopes. IsoMed Solutions bridges this gap by repurposing nuclear enrichment expertise to create non-proliferation compliant, low-enriched uranium targets that maximize medical yield while minimizing environmental impact.
Advanced Targetry
Sophisticated uranium target design that increases activation efficiency by up to 40% compared to legacy processes.
Non-Proliferation
Dedicated exclusively to LEU (Low Enriched Uranium) for safety and international regulatory compliance.
Rapid Transport
Custom logistics network designed to handle short half-life isotopes, ensuring they reach hospitals within hours.
Powering the next generation of cancer care.
Join us as we expand our research into alpha-emitting isotopes for targeted therapy.
Get in touch.
Our team of physicists and clinical advisors is available to discuss your high-purity isotope requirements.
123 Main St, Suite 456, Medical City, ST 12345
info@isomedsolutions.com
+1 (800) 555-0199